Regardless, in neuroblastoma cell lines in which ALK is either amplified (SK-N-AS: ALK is transcriptionally controlled by MYCN [90]) or mutated (LAN-5: ALKR1275Q [118]), MYCN was reported to disrupt the normal cellular circadian rhythm to promote a lipogenic transcriptional program [119]. Here, MYCN is linked to neuroblastoma.